The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Animal Therapeutics and Diagnostics-Global Market Insights and Sales Trends 2025
Synopsis
Diagnostic instruments aid in the determination of causative agents of diseases.
The global Animal Therapeutics and Diagnostics market size is expected to reach US$ 43500 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Therapeutics and Diagnostics in various end use industries. The expanding demands from the Companion Animals, Ruminants and Poultry,, are propelling Animal Therapeutics and Diagnostics market. Animal Diagnostics Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Therapeutics Products segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 17%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Therapeutics and Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Therapeutics and Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Therapeutics and Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Therapeutics and Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Therapeutics and Diagnostics covered in this report include Bayer, Eli Lilly and Boehringer Ingelheim,, Merck, Zoetis, Ceva Santé Animale, Sanofi and Nutreco, etc.
The global Animal Therapeutics and Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Eli Lilly
Boehringer Ingelheim
Merck
Zoetis
Ceva Santé Animale
Sanofi
Nutreco
Virbac
IDEXX Laboratories
Global Animal Therapeutics and Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Therapeutics and Diagnostics market, Segment by Type:
Animal Diagnostics Products
Animal Therapeutics Products
Global Animal Therapeutics and Diagnostics market, by Application
Companion Animals
Ruminants
Poultry
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Therapeutics and Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diagnostic instruments aid in the determination of causative agents of diseases.
The global Animal Therapeutics and Diagnostics market size is expected to reach US$ 43500 million by 2029, growing at a CAGR of 2.0% from 2023 to 2029. The market is mainly driven by the significant applications of Animal Therapeutics and Diagnostics in various end use industries. The expanding demands from the Companion Animals, Ruminants and Poultry,, are propelling Animal Therapeutics and Diagnostics market. Animal Diagnostics Products, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Therapeutics Products segment is estimated at % CAGR for the next seven-year period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 17%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Animal Therapeutics and Diagnostics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Animal Therapeutics and Diagnostics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Animal Therapeutics and Diagnostics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Animal Therapeutics and Diagnostics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Animal Therapeutics and Diagnostics covered in this report include Bayer, Eli Lilly and Boehringer Ingelheim,, Merck, Zoetis, Ceva Santé Animale, Sanofi and Nutreco, etc.
The global Animal Therapeutics and Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer
Eli Lilly
Boehringer Ingelheim
Merck
Zoetis
Ceva Santé Animale
Sanofi
Nutreco
Virbac
IDEXX Laboratories
Global Animal Therapeutics and Diagnostics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Animal Therapeutics and Diagnostics market, Segment by Type:
Animal Diagnostics Products
Animal Therapeutics Products
Global Animal Therapeutics and Diagnostics market, by Application
Companion Animals
Ruminants
Poultry
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Animal Therapeutics and Diagnostics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Animal Therapeutics and Diagnostics
1.1 Animal Therapeutics and Diagnostics Market Overview
1.1.1 Animal Therapeutics and Diagnostics Product Scope
1.1.2 Animal Therapeutics and Diagnostics Market Status and Outlook
1.2 Global Animal Therapeutics and Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Animal Therapeutics and Diagnostics Market Size by Region (2018-2029)
1.4 Global Animal Therapeutics and Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Animal Therapeutics and Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Animal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.1 North America Animal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.2 Europe Animal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Animal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.4 Latin America Animal Therapeutics and Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Animal Therapeutics and Diagnostics Market Size (2018-2029)
2 Animal Therapeutics and Diagnostics Market by Type
2.1 Introduction
2.1.1 Animal Diagnostics Products
2.1.2 Animal Therapeutics Products
2.2 Global Animal Therapeutics and Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Animal Therapeutics and Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Animal Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Animal Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Animal Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Animal Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Animal Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Animal Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
3 Animal Therapeutics and Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Companion Animals
3.1.2 Ruminants
3.1.3 Poultry
3.2 Global Animal Therapeutics and Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Animal Therapeutics and Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Animal Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Animal Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Animal Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Animal Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Animal Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Animal Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
4 Animal Therapeutics and Diagnostics Competition Analysis by Players
4.1 Global Animal Therapeutics and Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Therapeutics and Diagnostics as of 2022)
4.3 Date of Key Players Enter into Animal Therapeutics and Diagnostics Market
4.4 Global Top Players Animal Therapeutics and Diagnostics Headquarters and Area Served
4.5 Key Players Animal Therapeutics and Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Animal Therapeutics and Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer
5.1.1 Bayer Profile
5.1.2 Bayer Main Business
5.1.3 Bayer Animal Therapeutics and Diagnostics Products, Services and Solutions
5.1.4 Bayer Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer Recent Developments
5.2 Eli Lilly
5.2.1 Eli Lilly Profile
5.2.2 Eli Lilly Main Business
5.2.3 Eli Lilly Animal Therapeutics and Diagnostics Products, Services and Solutions
5.2.4 Eli Lilly Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Eli Lilly Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Animal Therapeutics and Diagnostics Products, Services and Solutions
5.3.4 Boehringer Ingelheim Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Recent Developments
5.5 Merck
5.5.1 Merck Profile
5.5.2 Merck Main Business
5.5.3 Merck Animal Therapeutics and Diagnostics Products, Services and Solutions
5.5.4 Merck Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 Merck Recent Developments
5.6 Zoetis
5.6.1 Zoetis Profile
5.6.2 Zoetis Main Business
5.6.3 Zoetis Animal Therapeutics and Diagnostics Products, Services and Solutions
5.6.4 Zoetis Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 Zoetis Recent Developments
5.7 Ceva Santé Animale
5.7.1 Ceva Santé Animale Profile
5.7.2 Ceva Santé Animale Main Business
5.7.3 Ceva Santé Animale Animal Therapeutics and Diagnostics Products, Services and Solutions
5.7.4 Ceva Santé Animale Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Ceva Santé Animale Recent Developments
5.8 Sanofi
5.8.1 Sanofi Profile
5.8.2 Sanofi Main Business
5.8.3 Sanofi Animal Therapeutics and Diagnostics Products, Services and Solutions
5.8.4 Sanofi Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 Sanofi Recent Developments
5.9 Nutreco
5.9.1 Nutreco Profile
5.9.2 Nutreco Main Business
5.9.3 Nutreco Animal Therapeutics and Diagnostics Products, Services and Solutions
5.9.4 Nutreco Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.9.5 Nutreco Recent Developments
5.10 Virbac
5.10.1 Virbac Profile
5.10.2 Virbac Main Business
5.10.3 Virbac Animal Therapeutics and Diagnostics Products, Services and Solutions
5.10.4 Virbac Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.10.5 Virbac Recent Developments
5.11 IDEXX Laboratories
5.11.1 IDEXX Laboratories Profile
5.11.2 IDEXX Laboratories Main Business
5.11.3 IDEXX Laboratories Animal Therapeutics and Diagnostics Products, Services and Solutions
5.11.4 IDEXX Laboratories Animal Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.11.5 IDEXX Laboratories Recent Developments
6 North America
6.1 North America Animal Therapeutics and Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Animal Therapeutics and Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Animal Therapeutics and Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Animal Therapeutics and Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Animal Therapeutics and Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Animal Therapeutics and Diagnostics Market Dynamics
11.1 Animal Therapeutics and Diagnostics Industry Trends
11.2 Animal Therapeutics and Diagnostics Market Drivers
11.3 Animal Therapeutics and Diagnostics Market Challenges
11.4 Animal Therapeutics and Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
